Loading clinical trials...
Loading clinical trials...
An Open-label, Multicenter, Single-arm, Phase 1 Study to Assess the Intrapulmonary Concentrations of Cefiderocol at Steady State in Hospitalized Subjects With Known or Suspected Bacterial Pneumonia on Treatment With Standard of Care Antibiotics and Requiring Mechanical Ventilation
Conditions
Interventions
Cefiderocol
Standard of Care Antibiotic
Locations
7
United States
Anschutz Medical Campus
Aurora, Colorado, United States
Hartford Hospital
Hartford, Connecticut, United States
University of Florida
Jacksonville, Florida, United States
U Miami Health Tower
Miami, Florida, United States
North Western University
Chicago, Illinois, United States
Creighton University
Omaha, Nebraska, United States
Start Date
February 20, 2019
Primary Completion Date
October 8, 2019
Completion Date
October 15, 2019
Last Updated
November 5, 2020
NCT06804096
NCT07004049
NCT06162286
NCT07386912
NCT05531149
NCT04215991
Lead Sponsor
Shionogi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions